129 related articles for article (PubMed ID: 11350596)
1. Transport characteristics of peptides and peptidomimetics: II. Hydroxyethylamine bioisostere-containing peptidomimetics as substrates for the oligopeptide transporter and P-glycoprotein in the intestinal mucosa.
Gao J; Winslow SL; Vander Velde D; Aubé J; Borchardt RT
J Pept Res; 2001 May; 57(5):361-73. PubMed ID: 11350596
[TBL] [Abstract][Full Text] [Related]
2. Transport characteristics of peptides and peptidomimetics: I. N-methylated peptides as substrates for the oligopeptide transporter and P-glycoprotein in the intestinal mucosa.
Gao J; Sudoh M; Aubé J; Borchardt RT
J Pept Res; 2001 Apr; 57(4):316-29. PubMed ID: 11328489
[TBL] [Abstract][Full Text] [Related]
3. Transport characteristics of peptidomimetics. Effect of the pyrrolinone bioisostere on transport across Caco-2 cell monolayers.
Sudoh M; Pauletti GM; Yao W; Moser W; Yokoyama A; Pasternak A; Sprengeler PA; Smith AB; Hirschmann R; Borchardt RT
Pharm Res; 1998 May; 15(5):719-25. PubMed ID: 9619780
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the bioconversion rates and the Caco-2 cell permeation characteristics of coumarin-based cyclic prodrugs and methylester-based linear prodrugs of RGD peptidomimetics.
Camenisch GP; Wang W; Wang B; Borchardt RT
Pharm Res; 1998 Aug; 15(8):1174-81. PubMed ID: 9706046
[TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
[TBL] [Abstract][Full Text] [Related]
8. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4.
Cummins CL; Jacobsen W; Benet LZ
J Pharmacol Exp Ther; 2002 Mar; 300(3):1036-45. PubMed ID: 11861813
[TBL] [Abstract][Full Text] [Related]
9. Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1.
Brodin B; Nielsen CU; Steffansen B; Frøkjaer S
Pharmacol Toxicol; 2002 Jun; 90(6):285-96. PubMed ID: 12403049
[TBL] [Abstract][Full Text] [Related]
10. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
11. Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism.
Guan Y; Huang J; Zuo L; Xu J; Si L; Qiu J; Li G
Arch Pharm Res; 2011 Oct; 34(10):1719-28. PubMed ID: 22076772
[TBL] [Abstract][Full Text] [Related]
12. Factors that restrict the intestinal cell permeation of cyclic prodrugs of an opioid peptide (DADLE): Part I. Role of efflux transporters in the intestinal mucosa.
Ouyang H; Chen W; Andersen TE; Steffansen B; Borchardt RT
J Pharm Sci; 2009 Jan; 98(1):337-48. PubMed ID: 18537149
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of (S)-valine thiazole-derived cyclic and noncyclic peptidomimetic oligomers as modulators of human P-glycoprotein (ABCB1).
Singh S; Prasad NR; Kapoor K; Chufan EE; Patel BA; Ambudkar SV; Talele TT
Chembiochem; 2014 Jan; 15(1):157-69. PubMed ID: 24288265
[TBL] [Abstract][Full Text] [Related]
14. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
Tang F; Horie K; Borchardt RT
Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
[TBL] [Abstract][Full Text] [Related]
15. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
[TBL] [Abstract][Full Text] [Related]
16. Monocarboxylate Transporter 13 (MCT13/SLC16A13) Functions as a Novel Plasma Membrane Oligopeptide Transporter.
Higuchi K; Kunieda M; Sugiyama K; Tomabechi R; Kishimoto H; Inoue K
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630718
[No Abstract] [Full Text] [Related]
17. Beta- and gamma-di- and tripeptides as potential substrates for the oligopeptide transporter hPepT1.
Hubatsch I; Arvidsson PI; Seebach D; Luthman K; Artursson P
J Med Chem; 2007 Oct; 50(21):5238-42. PubMed ID: 17887660
[TBL] [Abstract][Full Text] [Related]
18. Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450.
Zhu S; Huang R; Hong M; Jiang Y; Hu Z; Liu C; Pei Y
Eur J Pharm Sci; 2009 Jul; 37(5):573-80. PubMed ID: 19442720
[TBL] [Abstract][Full Text] [Related]
19. An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routes.
Tavelin S; Taipalensuu J; Hallböök F; Vellonen KS; Moore V; Artursson P
Pharm Res; 2003 Mar; 20(3):373-81. PubMed ID: 12669956
[TBL] [Abstract][Full Text] [Related]
20. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
